SERPINC1 and Venous thrombosis: Systemic inflammation and a reduction in antithrombin III (AT III) activity induce a state of hypercoagulability that, when associated with blood stasis and vascular endothelial damage, may lead to thrombosis and/or disseminated intravascular coagulation (DIC), worsening the prognosis.